Save 20% on Press Releases and More with NNW Prime! Click to View Details
MondayMar 18, 2019 1:30 pm

Issuer Direct Corp. (NYSE American: ISDR) Attends 31st Annual ROTH Conference

Issuer Direct (NYSE American: ISDR) is an industry-leading communications and compliance company focusing on the needs of corporate issuers. Issuer Direct's principal platform, Platform id., empowers users by thoughtfully integrating the most relevant tools, technologies and services, thus eliminating the complexity associated with producing and distributing financial and business communications. Headquartered in RTP, NC, Issuer Direct serves more than 2,500 public and private companies in more than 18 countries. For more information, visit the company's website at www.issuerdirect.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services…

Continue Reading

MondayMar 18, 2019 1:30 pm

IRIDEX Corp. (NASDAQ: IRIX) Attends 31st Annual ROTH Conference

IRIDEX (NASDAQ: IRIX) develops, manufactures and markets innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The company’s proprietary MicroPulse technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions. IRIDEX’s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX’s products are sold in the United States through a direct sales force and internationally primarily through a network of independent distributors into more than 100 countries. For more information, visit the company's website at www.iridex.com. About NetworkNewsWire…

Continue Reading

MondayMar 18, 2019 1:30 pm

IRadimed Corp. (NASDAQ: IRMD) Attends 31st Annual ROTH Conference

IRadimed (NASDAQ: IRMD) is a leader in the development of innovative magnetic resonance imaging compatible medical devices. IRadimed is the only known provider of a non-magnetic intravenous infusion pump system specifically designed to be safe for use during MRI procedures. The company was the first to develop an infusion delivery system that largely eliminates many of the dangers and problems present during MRI procedures. IRadimed’s patented MRidium MRI-compatible IV infusion pump system is designed with a non-magnetic ultrasonic motor, uniquely-designed non-ferrous parts and other special features to safely and predictably deliver anesthesia and other IV fluids during various MRI procedures.…

Continue Reading

MondayMar 18, 2019 1:30 pm

Intrinsyc Technologies Corp. (TSX: ITC) (OTCQX: ISYRF) Attends 31st Annual ROTH Conference

Intrinsyc Technologies (TSX: ITC) (OTCQX: ISYRF) is a product development company that provides comprehensive and tailored solutions that enable the development and production of next-generation embedded and IoT devices. Solutions span the development life cycle from concept to production and help device makers and technology suppliers create compelling differentiated products with faster time-to-market. For more information, visit the company's website at www.intrinsyc.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2)…

Continue Reading

MondayMar 18, 2019 1:30 pm

InterDigital Inc. (NASDAQ: IDCC) Attends 31st Annual ROTH Conference

InterDigital (NASDAQ: IDCC) develops mobile technologies that are at the core of devices, networks and services worldwide. The company solves many of the industry's most critical and complex technical challenges, inventing solutions for more efficient broadband networks and a richer multimedia experience that is years ahead of market deployment. InterDigital has licenses and strategic relationships with many of the world's leading wireless companies. For more information, visit the company's website at www.interdigital.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets,…

Continue Reading

MondayMar 18, 2019 1:30 pm

Aly Energy Services Inc. (ALYE) Attends 31st Annual ROTH Conference

Aly Energy Services (OTCQB: ALYE) and its subsidiaries provide equipment and services essential to the drilling and development of oil and gas resources, including mud delivery, solids control, fluid management, and directional drilling and measurement-while-drilling services. The company serves the Permian Basin (in Texas and New Mexico), Eagle Ford Shale, Utica Shale, Marcellus Shale, Woodford Shale, Granite Wash, Mississippian Lime, and Tuscaloosa Marine Shale. For more information, visit the company's website at www.alyenergy.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets,…

Continue Reading

MondayMar 18, 2019 1:30 pm

Intec Pharma Ltd. (NASDAQ: NTEC) Attends 31st Annual ROTH Conference

Intec Pharma (NASDAQ: NTEC) is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology. The company's Accordion Pill is an oral drug delivery system that is designed to improve the efficacy and safety of existing drugs and drugs in development by utilizing an efficient gastric retention and specific release mechanism. The company's product pipeline includes two product candidates in clinical trial stages: Accordion Pill Carbidopa/Levodopa which is in late-stage phase 3 development for the treatment of Parkinson's disease symptoms in advanced Parkinson's disease patients; and AP-cannabinoids, an Accordion Pill to deliver cannabinoids. For…

Continue Reading

MondayMar 18, 2019 1:30 pm

Altimmune Inc. (NASDAQ: ALT) Attends 31st Annual ROTH Conference

Altimmune (NASDAQ: ALT) is a clinical-stage immunotherapeutics company focused on the development of products to stimulate robust and durable immune responses for the prevention and treatment of diseases. The company strategically employs two distinct and complementary immune platform technologies to create innovative candidates for important diseases. By leveraging the complementary attributes of its proprietary technology platforms, Altimmune is able to design and develop immunotherapeutic products tailored to address a wide range of disease indications including both acute and chronic infections and cancer. For more information, visit the company's website at www.altimmune.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and…

Continue Reading

MondayMar 18, 2019 1:00 pm

Allied Motion Technologies Inc. (AMOT) Attends 31st Annual ROTH Conference

Allied Motion Technologies (NASDAQ: AMOT) designs, manufactures and sells precision and specialty motion control components and systems used in a broad range of industries within major markets, including vehicle, medical, aerospace & defense, and industrial.  Allied Motion is focused on motion control applications and is known worldwide for its expertise in electro-magnetic, mechanical and electronic motion technology.  Its products include brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gear motors, gearing, modular digital servo drives, motion controllers, incremental and absolute optical encoders, and other associated motion control-related products.   For more information, visit…

Continue Reading

MondayMar 18, 2019 1:00 pm

Allena Pharmaceuticals Inc. (NASDAQ: ALNA) Attends 31st Annual ROTH Conference

Allena Pharmaceuticals (NASDAQ:  ALNA) is a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders. Allena’s lead product candidate, reloxaliase, is a first in class, oral enzyme therapeutic for the treatment of hyperoxaluria, a metabolic disorder characterized by markedly elevated urinary oxalate levels and commonly associated with kidney stones, chronic kidney disease and other serious kidney disorders. For more information, visit the company's website at www.allenapharma.com. About NetworkNewsWire NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000